Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinoma

BACKGROUND: Neoadjuvant chemoradiotherapy (neoCRT) followed by surgery is the most common approach for locally advanced resectable esophageal squamous cell carcinoma (ESCC) patients. How neoCRT impacts ESCC tumor immune microenvironment (TIME) has not been fully understood. METHODS: Single-cell RNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Jing, Fang, Shuogui, Hu, Yi, Xi, Mian, Weng, Zelin, Pan, Chuqing, Luo, Kongjia, Ling, Yihong, Lai, Renchun, Xie, Xiuying, Lin, Xiaodan, Lin, Ting, Chen, Jiyang, Liu, Qianwen, Fu, Jianhua, Yang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699982/
https://www.ncbi.nlm.nih.gov/pubmed/36434949
http://dx.doi.org/10.1016/j.ebiom.2022.104371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699982/
https://www.ncbi.nlm.nih.gov/pubmed/36434949
http://dx.doi.org/10.1016/j.ebiom.2022.104371

Ejemplares similares